Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.
Helen S MarshallMark McMillanAnn P KoehlerAndrew LawrenceThomas R SullivanJenny M MacLennanMartin Christopher James MaidenShamez N LadhaniMary E RamsayCaroline TrotterRay BorrowAdam FinnCharlene M KahlerJane WhelanKumaran VadiveluPeter RichmondPublished in: The New England journal of medicine (2020)
Among Australian adolescents, the 4CMenB vaccine had no discernible effect on the carriage of disease-causing meningococci, including group B. (Funded by GlaxoSmithKline; ClinicalTrials.gov number, NCT03089086.).
Keyphrases